Follistim (TM) (follitropin beta for injection)
Company: Organon
Approval Status: Approved September 1997
Treatment for: infertility
Areas: Endocrinology; Obstetrics/Gynecology
General Information
Other Useful Resources
The U.S. Food and Drug Administration approved Oregonon's Follistim (TM) (follitropin beta for injection), the first recombinant follicle-stimulating hormone available in the U.S. for the treatment of infertility. Follistim works by stimulating ovaries to produce one or more eggs during each treatment.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
